2552 — Hua Medicine Balance Sheet
0.000.00%
Last trade - 00:00- HK$3.61bn
- HK$2.76bn
- CNY255.89m
Annual balance sheet for Hua Medicine, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 675 | 491 | 1,461 | 1,140 | 1,092 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.411 | 415 | 10.9 | 52.3 | 82.5 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 705 | 940 | 1,572 | 1,336 | 1,296 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 157 | 140 | 115 | 130 | 110 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 904 | 1,121 | 1,725 | 1,527 | 1,470 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 107 | 188 | 252 | 330 | 210 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 453 | 842 | 1,624 | 1,663 | 463 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 450 | 280 | 101 | -135 | 1,006 |
| Total Liabilities & Shareholders' Equity | 904 | 1,121 | 1,725 | 1,527 | 1,470 |
| Total Common Shares Outstanding |